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Plasma cells (PCs) are defined as terminally differentiated B cells that secrete large 
amounts of immunoglobulin (Ig). PCs that reside in the bone marrow (BM) are respon-
sible for maintaining long-term antibody (Ab) responses after infection and vaccination, 
while PCs present in the blood are generally short-lived. In rhesus macaques, a species 
frequently used for the evaluation of human vaccines, B cells resemble those found in 
humans. However, a detailed characterization of BM-resident rhesus PC phenotype and 
function is lacking. Here, we examined Ig secretion of distinct rhesus CD138+ popu-
lations by B cell ELISpot analysis to couple phenotype with function. We demonstrate 
that the CD20low/−CD138+CD31+ BM population was highly enriched for antibody- 
secreting cells with IgG being the predominant isotype (60%), followed by IgA (33%) 
and IgM (7%). Transmission electron microscopy analysis confirmed PC enrichment in 
the CD20low/−CD138+CD31+ population with cells containing nuclei with “spokes of a 
wheel” chromatin structure and prominent rough endoplasmic reticulum. This panel also 
stained human BM PCs and allowed a clear distinction between BM PCs and short-lived 
peripheral PCs, providing an improved strategy to isolate PCs from rhesus BM for further 
analysis.
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inTrODUcTiOn
Durable immunity relies on constitutive antibody (Ab) production by terminally differentiated, 
long-lived bone marrow (BM)-resident plasma cells (PCs). These cells are products of the 
germinal center (GC) reaction where B cells proliferate upon recognition of cognate antigen 
in a T helper cell-dependent manner. Following somatic hypermutation (SHM) of Ab variable 
domains, selected B cells differentiate either into memory B cells or PCs prior to exiting the GC 
[reviewed in Ref. (1)]. Blimp-1, along with XBP-1 and IRF-4, is a key transcription factor for 
the transition to fully differentiated PCs (2).
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In acute inflammatory situations, such as in response to infec-
tion or immunization, new peripheral PCs are generated. These 
cells are short-lived and migrate toward the inflammatory sites 
to secrete antigen-specific antibodies (3, 4). The BM is the main 
compartment where long-lived PCs persist in healthy individu-
als, and homing to this compartment is essential for long-term 
serological memory. This process is tightly regulated by the 
expression of adhesion molecules, chemokines and their recep-
tors, where CXCL12 and its receptor, CXCR4, play major roles 
(5, 6). The BM provides a milieu that supports the persistence 
of long-lived PCs (7). Its cellular components consist mainly of 
CXCL12+VCAM+ stromal cells and hematopoietic cells (5, 8), 
including eosinophils and megakaryocytes, capable of secreting 
IL-6 and APRIL that regulate the frequency and survival of PCs 
via their receptors IL-6R and BCMA/TACI (9–11), respectively 
(9–12). BAFF and APRIL signaling upregulates the expression 
of the anti-apoptotic molecule Mcl-1, which is essential for the 
long-term survival of PCs (13). In addition, the B cell intrinsic 
program that is imprinted during the GC reaction by intrinsic 
factors is indispensable for determining the fate and maintaining 
durable Ab responses (12, 14).
In humans, BM-resident PCs are typically defined by the 
expression of CD38 and CD138 as well as heterogeneous CD19 
expression (15), combined with their ability to secrete Ab or 
stain positively for cytoplasmic Ig. Recent studies reported that 
of these PCs, the CD19− cells display a more differentiated 
phenotype (16) that was associated with a longer life span (17) 
compared to CD19+ PCs. Less information is available about 
BM-resident PCs in non-human primates. Rhesus macaques 
are frequently used to model human immunology. With the 
publishing of the rhesus macaque genome (18) and the devel-
opment of protocols to phenotype rhesus B cell populations 
and PCR amplify rhesus immunoglobulin (Ig) genes (19, 20), 
examination of B cell responses in this species is now more 
accessible.
Phenotypic characterization of PCs in rhesus macaques has 
primarily focused on the analysis of blood where plasmablasts 
are abundant 1  week following immunization (21, 22). Two 
recent reports describe phenotypic analysis of BM-resident PCs 
in macaques based on markers that work well for human BM 
PCs, including CD138, CD38, CD27, and/or CD19 (23, 24). 
However, as these markers are also expressed on other cell types 
and their pattern of expression may be different in macaques, 
efforts to characterize additional markers that distinguish rhesus 
macaque BM PCs are needed. Here, we describe a comprehensive 
phenotypic and functional characterization of rhesus macaque 
BM PCs. Specifically; we show that antibody-secreting cells 
(ASC) are contained within the CD20low/−CD138+CD31+ 
population. This staining panel discriminated BM PCs from 
peripheral plasmablasts and was also suitable for staining 
human BM PCs. We show further that the CD19 and CD38 
markers, often used to define human BM PCs, are suboptimal 
for defining rhesus macaque BM PCs due to reduced cross-
reactivity and/or different expression patterns. Finally, we show 
that cryopreservation of rhesus BM cells led to a selective loss of 
the CD20low/−CD138+CD31+ population, which has practical 
implications for studies of BM PCs.
MaTerials anD MeThODs
ethics statement
The animal work was conducted with the approval of the regional 
Ethical Committee on Animal Experiments (Stockholms Norra 
Djurförsöksetiska Nämnd), while the human work was con-
ducted with the approval of the regional ethical vetting board 
in Stockholm with the registration number 2015/305-31/1. All 
methods were carried out in accordance with the approved 
guidelines.
animals
Rhesus macaques (Macaca mulatta) of Chinese origin, ~5–6 years 
old, were housed at the Astrid Fagraeus Laboratory facility at 
Karolinska Institutet, as previously described (21, 25). Housing 
and care procedures were in compliance with the provisions and 
general guidelines of the Swedish Board of Agriculture, and the 
facility has been assigned an Animal Welfare Assurance number 
by the Office of Laboratory Animal Welfare (OLAW) at the 
National Institutes of Health (NIH). The macaques were housed 
in pairs in 4 m3 cages, enriched to give them the possibility to 
express their physiological and behavioral needs. They were 
habituated to the housing conditions for more than 6  weeks 
before the start of the experiment and subjected to positive 
reinforcement training in order to reduce the stress associated 
with experimental procedures. All immunizations and blood 
samplings were performed under sedation with ketamine 
10–15  mg/kg intramuscularly (i.m.) (Ketaminol 100  mg/ml, 
Intervet, Sweden). BM aspirates were collected as described pre-
viously (26). The macaques were weighed at each sampling. All 
animals were confirmed negative for simian immunodeficiency 
virus (SIV), simian T-cell lymphotropic virus, simian retrovirus 
type D, and simian Herpes B virus.
human subjects
Bone marrow cells from three adult human subjects were acquired 
in conjunction with hip-replacement surgery at the Orthopedics 
Clinic, Karolinska University Hospital, in Stockholm. Oral and 
written consent was obtained.
isolation and cryopreservation of 
Mononuclear cells from Blood and Bone 
Marrow
Mononuclear cells from peripheral blood and BM were isolated 
within 2 h of sample collection using BD Vacutainer® K2 EDTA 
tubes. Tubes were immediately inverted 8–10 times, and blood 
tubes were centrifuged at 15 min at 2400 rpm at 25°C to separate 
the plasma. Blood or BM cells were diluted in sterile PBS and 
layered on top of Ficoll-Paque™ (GE Healthcare Life Sciences) at 
a 2:1 ratio, and the tubes were centrifuged at 30 min at 2200 rpm 
at 25°C without break. A 5 ml sterile serological pipette was used 
to isolate the buffy coat layer in a 50 ml conical tube. The cells 
were washed twice with PBS (1750 rpm, 10 min, 25°C), 3 ml of 
lysis buffer was added for 5  min, and cells were washed twice 
with PBS (1500 rpm, 10 min, 25°C) and resuspended in 5 ml of 
PBS with 5% FBS (Sigma) per tube of blood collected. The cells 
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were counted using 0.4% trypan blue exclusion countess (Life 
Technologies). An aliquot of the cells was used fresh in ELISpot 
assays, and the remaining cells were frozen at 10–15 × 106/ml/
cryovial in Fetal Bovine Serum (FBS) with 10% DMSO chilled 
at 4°C. Cryovials containing cells were placed in an ice bath for 
15 min prior to placing in a “Mr. Frosty” (Nalgene) cryocontainer 
before transfer, first to −80°C for 24 h and then, to liquid nitro-
gen tanks. To thaw the cells, the cryovials were removed from 
the liquid nitrogen and brought on dry ice to the lab. Vials were 
thawed immediately while shaking in a 37°C water bath until a 
few ice crystals remained. No more than one cryovial was thawed 
at the same time. The cell suspension was transferred into a 10 ml 
of pre-warmed RPMI 1640 media (Sigma), supplemented 10% 
FCS (Sigma), 2 mM l-glutamine, 100 U/ml penicillin, 100 mM 
streptomycin, and 2% HEPES (supplemented media), all from 
Life Technologies. The tubes were centrifuged at 1500 rpm for 
5 min with the brake set at low speed. After one additional wash 
in supplemented media, the cells were resuspended in 5 ml of 
PBS. Cells were counted and viability assessed using 0.4% trypan 
blue exclusion. The viability typically ranged from 85 to 95%.
Flow cytometry of BM Pcs
Frozen BM cells were thawed at 37°C and washed twice in pre-
warmed supplemented media. Cells were washed twice with 
PBS and counted using 0.4% trypan blue exclusion countess 
(Life Technologies), and the cell viability was consistently 
>90%. Cells were resuspended in 100  μl of PBS in a 96-well 
plate (1–4 × 106 cells/well) and incubated for 10 min at 4°C with 
FcR blocking (eBioscience or BD) for rhesus and human cells 
respectively, and Aqua Dead Cell Stain Kit (Molecular Probes). 
Cells were washed with FACS buffer (PBS + 2% FBS). Rhesus cells 
were surface-stained with antibodies against CD3 clone SP34-2 
BV786 (BD), CD20 clone 2H7 BV421 (BD), CD138 clone DL101 
PE (eBioscience), CD49d clone 9F10 PerCp-Cy5.5 (eBioscience), 
CD31 clone WM59 Alexa 647 (BD), CD98 clone 5E5 FITC 
(eBioscience), CD19 clone J3-119 PE-Cy7 (Beckman Coulter), 
and CD38 clone OKT10 APC (NIH Non-human primate reagent 
resource). Human cells were surface-stained using the same Ab 
panel as used for macaques with the exception of CD38 [clone 
HIT2 APC (BD)]. All Abs were previously titrated for optimal 
staining of rhesus macaque and human peripheral blood mono-
nuclear cells (PBMCs). Samples were collected on a FACS LSRII 
or sorted using a FACS ARIA FUSION (BD Immunocytometry 
Systems) and analyzed using FlowJo software.
Flow cytometry of circulating 
Plasmablasts in rhesus Macaque Blood
Frozen PBMCs were thawed, and cell viability was consistently 
>90%. After the incubation with the FcR blocking (BD) and 
Aqua Dead Cell Stain (Molecular Probes), as described in Section 
“Flow Cytometry of BM PCs,” the cells were washed with FACS 
buffer and surface-stained for 15  min at 4°C with antibodies 
against CD3 BV786 (BD), CD20 BV421 (BD), CD138 PE 
(eBioscience), CD80 clone L307.4 APC-H7 (BD), HLA-DR clone 
L243 PerCP-Cy5.5 (BD), CD14 clone M5E2 BV786 (BD), CD16 
clone 3G8 BV786 (BD), CD98 FITC (eBioscience), and CD49d 
APC (BD) or CD31 Alexa 647 (BD). Cells were washed twice 
with FACS buffer and incubated in 100 μl of Cytofix/Cytoperm 
(BD) for 20 min at 4°C. Cells were then washed twice in Perm/
Wash buffer (BD) and intracellularly stained in 100 μl of Perm/
Wash buffer for 15 min at 4°C with IgG clone G18-145 PE-Cy7 
(BD), followed by two washes in Perm/Wash buffer and two 
in FACS buffer. All Abs were previously titrated for optimal 
staining of rhesus macaque PBMCs. Samples were collected on 
a FACS LSRII (BD Immunocytometry Systems) and analyzed 
using FlowJo software.
B cell elispot assay
Plasma cells were enumerated as previously described (21). In 
brief, to evaluate the presence of BM PCs, defined as spontaneous 
ASC, different gate populations were sorted into supplemented 
media and plated directly into ELISpot plates. To detect ASC, 
MAIPSWU10 96-well plates (Millipore) were coated with 10 μg/ml 
antihuman IgG, IgA, and IgM (Fcγ, Fcα, and Fcμ chain) (Jackson 
ImmunoResearch), and cells were transferred to the plates in 
dilution series and incubated for 18 h at 37°C, 5% CO2. The plates 
were then washed with PBS containing 0.05% Tween and incu-
bated with biotinylated antihuman IgG, IgA, or IgM (0.25 μg/
ml) for 1.5 h at 37°C followed by washing and incubation with 
streptavidin-AP (1:1000, Mabtech). The reactions were developed 
using BCIP/NBT substrate (Sigma) and stopped by washing in 
distilled water. Spots corresponding to ASC were counted using 
an ImmunoSpot® analyzer (Cellular Technology Ltd.). The results 
were converted to show percentage of ASC of plated events.
Transmission electron Microscopy
CD138+CD31+ cells were sorted from a frozen sample, and 
34,000 events were acquired into supplemented media. The cells 
were washed twice with PBS before fixing in 2.5% glutaralde-
hyde in 0.1M phosphate buffer, pH 7.4 at +4°C overnight, and 
centrifuged to a pellet. The pellet was rinsed in 0.1M phosphate 
buffer, pH 7.4. A small amount of 10% gelatine was added on 
top of the small pellet and left to solidify. The pellet was then 
fixed in 2% osmium tetroxide in 0.1M phosphate buffer, pH 7.4 
at +4°C for 2 h, dehydrated in ethanol followed by acetone and 
embedded in LX-112 (Ladd, Burlington, VT, USA). Ultrathin 
sections (~50–60 nm) were cut using a Leica EM UC 6 (Leica, 
Wien, Austria). Sections were contrasted with uranyl acetate 
followed by lead citrate and visualized in a Hitachi HT 7700 
(Tokyo, Japan) at 80  kV. Digital images were taken by using 
a Veleta camera (Olympus Soft Imaging Solutions, GmbH, 
Münster, Germany).
statistical analysis
All statistical analysis was done with GraphPad Prism software 
version 6 and considered significant at *p ≤  0.05, **p ≤  0.01, 
***p ≤  0.001, and ****p ≤  0.0001. Comparisons of ≥3 groups 
were analyzed by the ANOVA non-parametric Kruskal–Wallis 
test followed by Dunn’s post test for individual comparisons. 
For repetitive measures, ANOVA was used. When comparing 
two groups, t-test or Mann–Whitney test were used. To analyze 
groups with multiple factors, two-way ANOVA was used followed 
FigUre 1 | rhesus BM igg asc are found in the cD20low/−cD3−cD138+ population. (a) FACS gating strategies for CD20+ (blue), CD20− (gray) 
populations gated from live, CD3− cells, and for CD138+ (orange) and CD138− (purple) populations gated from live, CD3−CD20low/− rhesus cells. (B) Frequency 
(mean and SD) of rhesus CD20+, CD20−, and CD138+, CD138− cells from the live, CD3−. Mann–Whitney test was done ****p < 0.0001 (n = 9). (c) ELISpot for 
total IgG ASC from the sorted populations shown in (a) are CD138+ (orange sort gate), CD138− (purple sort gate), and CD3−CD20+ (gray sort gate). Data from 
three different animals are shown, and the sorted cells were plated in two different dilutions (left panel). Frequency (mean and SD) of total IgG ASC in the three 
sorted populations are labeled as: CD138+, CD138−, and CD3−CD20+. Kruskal–Wallis test followed by Dunn’s multiple comparison were performed *p < 0.05 and 
**p < 0.01 (n = 5). All data were obtained from frozen samples.
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by Bonferroni’s post test for multiple comparisons. The relation-
ship between variables was established with the non-parametric 
Spearman’s correlation analysis.
resUlTs
cD3−cD20low/−cD138+ Bone Marrow 
cells in rhesus Macaques are enriched 
for igg-secreting cells
Bone marrow-resident PCs in humans are phenotypically defined 
as CD3 negative cells that have downregulated their surface 
expression of CD20 and express high levels of CD38 and CD138. 
Functionally, the hallmark of PCs is their capacity to secrete Ab 
constitutively both in vivo and when cultured in vitro. In rhesus 
macaques, which closely mimic humans both genetically and 
in regards to immune cell phenotypes, BM PCs were defined as 
CD20−CD19+CD38+CD138+ cells (23, 24). While this provides 
a useful starting point, it was shown that the CD19+CD20− 
population in cynomolgus macaques contained rhesus B-1-like 
B cells (27), and in humans, both CD19+ and CD19− popula-
tions harbor BM PCs (16, 17). Furthermore, currently available 
CD19 antibodies stain rhesus CD19 suboptimally (Figure S1 in 
Supplementary Material); thus, the definition of additional mark-
ers of rhesus BM PCs coupled with functional analysis is needed 
for improved definition of these cells.
To meet this objective, we first examined if CD3−CD20low/− 
CD138+ BM cells could be functionally defined as Ab-secreting 
PCs (23, 24). We stained Ficoll-separated BM cells from nine 
rhesus macaques for CD3, CD20, and CD138. The analysis of one 
representative animal is shown as dot plots (Figure 1A), and data 
from all nine macaques are shown as mean values (Figure 1B). 
The mean frequency of CD3−CD20+ cells of live cells was 
15 ±  7%, while the mean frequency of CD3−CD20low/− cells 
in the live gate was 85 ± 7%. To stain for CD138, we used the 
DL101 Ab clone, which previously was demonstrated to be cross-
reactive with rhesus macaque CD138 (22–24). Staining of the 
LiveCD3−CD20low/− population resulted in distinct CD138− 
and CD138+ populations with 1.62% of the LiveCD3−CD20low/− 
cells being CD138+ in the representative animal (Figure 1A), and 
the mean frequency of CD138+ cells of the LiveCD3− cells for 
the nine macaques was 1.8 ± 0.8% (Figure 1B). We next wished 
to couple phenotype to function and sorted three populations of 
cells, LiveCD3−CD20+ cells, LiveCD3−CD20low/−CD138− 
cells, and LiveCD3−CD20low/−CD138+ cells, from three 
macaques. The cells were sorted directly into ELISpot plates 
coated with anti-IgG Ab and incubated for 18  h without 
additional stimulation to assess their capacity to constitu-
tively produce IgG. IgG-secreting PCs were observed in the 
CD3−CD20low/−CD138+ population (8 ±  4%), while virtu-
ally no IgG ASC were observed in the other two populations 
CD3−CD20+ (0.08  ±  0.1%) and CD3−CD20low/−CD138− 
(0.03 ± 0.06%), respectively (Figure 1C). Considering that only 
8% of CD3−CD20low/−CD138+ BM cells produced IgG, it 
appeared likely that a large proportion of the CD138+ cells were 
not functional PCs. Therefore, we examined the CD138+ cells for 
additional markers that would allow for an improved enrichment 
of Ab-secreting BM cells.
igg-, iga-, and igM-secreting BM Pcs 
are contained Within the  
cD138+cD31+ Population
To identify additional markers that could enrich rhesus macaque 
BM PCs, we selected three molecules that were previously 
reported to be expressed by human or mouse PCs: CD49d, 
shown to be highly expressed on human BM PCs (15, 28), 
CD31, reported to be expressed on PCs in human spleen and 
FigUre 2 | cD31, cD49d, and cD98 expression of cD138+ rhesus bone marrow cells. (a) Representative FACS plots showing CD138+CD31+, 
CD138+CD49d+, and CD138+CD98+ populations gated from live, CD3−CD20low/− cells in the same stain of rhesus bone marrow. (B) Frequency (mean) of 
CD138+CD31+, CD138+CD49d+, and CD138+CD98+ populations (upper panel). Correlations between CD138+CD31+, CD138+CD49d+, and CD138+CD98+ 
populations were analyzed using non-parametric Spearman (r) (**p < 0.01) and linear regression (middle and lower panels) n = 9. All data were obtained from frozen 
samples.
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BM (29), and CD98, which was recently suggested to be a marker 
of mouse PCs (30). We stained rhesus macaque CD138+ BM 
cells for CD31, CD49d, and CD98 and found that all three 
markers co-stained a subset of the CD138+ cells (Figure  2A). 
There was no statistically significant difference between the 
CD138+CD31+ (0.95 ± 0.4%), CD138+CD49d+ (0.8 ± 0.4%), 
and CD138+CD98+ (0.7 ±  0.4%) populations. We observed a 
high correlation in the frequencies between the CD138+CD31+ 
population, the CD138+CD49d+ (r = 0.9, **p < 0.01), and the 
CD138+CD98+ (r =  0.8, **p <  0.01) population (Figure  2B), 
which suggests that CD31, CD49d, and CD98 stained the same 
population. Therefore, we focused on one of the markers, CD31, 
for the subsequent analysis.
To determine which population harbored Ab-secreting PCs, 
we next sorted LiveCD3−CD20low/−CD138+CD31+ and Liv
eCD3−CD20low/−CD138+CD31− cells from fresh rhesus BM 
into anti-IgG-, anti-IgA-, or anti-IgM-coated ELISpot plates. 
LiveCD3−CD20low/−CD138− cells were included as a nega-
tive control (Figure 3A, upper panel). Only the double-positive 
CD138+CD31+ population was significantly enriched for ASC 
(Figure 3A, lower panel). Combining the results obtained from 
12 animals, we found that 24% of the plated CD138+CD31+ 
cells produced antibodies with the majority being of IgG isotype 
(14.5 ± 6.0%), followed by IgA (7.9 ± 3.7%) and IgM (1.8 ± 1.2%) 
(Figure 3B). These findings are consistent with studies of human 
BM PCs (16). When the plated CD138+CD31− cells were similarly 
analyzed, we found that 3% of the plated cells secreted antibodies 
with no significant difference between the IgG- (1.6 ± 2.5%), IgA- 
(1.1 ± 2.2%), and IgM-secreting (0.2 ± 0.2%) cells (Figure 3B). To 
assess PC enrichment in the sorted CD138+CD31+ population 
by morphological analysis, we performed Transmission Electron 
Microscopy (TEM). We found that PCs were the predominant 
cell type in these specimens, as distinguished by characteristic 
PC morphology, including nuclei with “spokes of a wheel” 
chromatin structure and prominent rough ER in the majority of 
the cells (Figure 3C). Altogether, these results illustrate that the 
CD138+CD31+ rhesus BM population comprises the functional 
IgG-, IgA-, and IgM-secreting PC compartment.
FigUre 4 | circulating plasmablasts in rhesus macaques are 
phenotypically distinct from BM Pcs. (a) Representative intracellular (IC) 
IgG plot (left panel) of rhesus peripheral PCs and percentages IC IgG+ cells 
of CD14−CD16−CD20low/−HLA-DR+CD80+ cells from day 7 
postimmunization (n = 3) (right panel). (B) Frequency of IC IgG+ peripheral 
PCs in rhesus PBMCs collected on days 0, 7, and 14 postimmunization. To 
determine statistical significance, *p < 0.05, ANOVA was used for repetitive 
measures followed by Holm–Sidak’s multiple comparison (c) Percentages of 
CD138+CD31+ (orange), CD138+CD49d+ (red), and CD138+CD98+ 
(brown) populations (defined in Figure S2B in Supplementary Material) in 
IC IgG+ peripheral PCs. Each bar represents the mean, and each circle 
represents one animal (n = 3). All data were obtained from frozen samples.
FigUre 3 | igg-, iga- and igM-secreting Pcs are found in the 
cD138+cD31+ population. (a) Representative FACS plot showing the 
gates of the three sorted populations (red gates), CD138+CD31+, 
CD138+CD31−, and CD138− (upper panel). Representative B cell ELISpot 
data of three experiments showing the sorted populations tested for IgG, 
IgA, and IgM secretion. 2000 events were sorted from each population, 2 
dilutions of cells were plated at fourfold dilutions (blue arrows) (lower 
panel). (B) Frequencies (mean and SD) of IgG (green), IgA (orange), and 
IgM (red) ASC of total plated events from the three sorted populations. Pie 
chart of the CD138+CD31+ population, 60% of the cells secreted IgG 
(green), 32.5% IgA (orange), and 7.5% IgM (red). Data were obtained from 
fresh rhesus BM (n = 12). Two-way ANOVA followed by Tukey’s multiple 
comparison test was performed, ****p < 0.0001. (c) TEM analysis of cells 
sorted from the CD138+CD31+ population, exhibiting characteristic 
plasma cell morphology with typical “spokes of a wheel” chromatin 
structures, and prominent and dilated RER. Two different magnifications 
are shown with scale bars of 2 μm (left panel) and 1 μm (right panel). 
(a,B) data were obtained from fresh samples. (c) data were obtained from 
frozen samples.
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co-expression of cD138, cD31, cD49d, 
and cD98 Distinguishes BM Plasma cells 
from Peripheral Plasma cells
We next sought to examine if the expression pattern of 
CD138, CD31, CD49d, and CD98 on blood PCs was similar 
to the one found in BM PCs. Circulating rhesus plasmablasts 
peaking 1  week after immunization were recently defined as 
CD3−CD16−CD20−/intHLA-DR+CD14−CD11c−CD123
−CD80+ cells (22). We used the same staining panel with the 
exception of CD11c and CD123 (Figure S2A in Supplementary 
Material). To determine the percentage of these cells that co-
stained with IC IgG, we examined samples collected 7  days 
after vaccination from a previous study (21). We found that 
47  ±  14% of the LiveCD3−CD16−CD14−CD20−/intHLA-
DR+CD80+ were  positive for IC IgG (Figure  4A). Thus, 
FigUre 5 | examination of cD19 and cD38 expression on human and rhesus cD3−cD20low/−cD138+cD31+ BM cells. Flow cytometric analysis of 
(a) human BM and (B) rhesus BM using the CD138+CD31+ gating strategy with the addition of CD38 and CD19. CD138+CD31+ cells were gated from live 
CD3−CD20low/−. (c) Representative histogram of CD38 expression showing that CD138+CD31+ cells co-expressed CD38 in both human and rhesus BM, but with 
lower staining intensity in rhesus BM. (D) Representative histograms of the CD38 marker showing the separation of CD138+CD31+ from the CD138+CD31− population 
in human cells (dark and light green, respectively) and in rhesus cells (dark and light blue, respectively). (e) Percentages of CD38+ cells within the CD138+CD31+ 
population (top panel) and CD138+CD31− population (bottom panel) for human cells (green) and rhesus cells (blue). Unpaired t-tests were done using Welch’s correction 
to determine statistical significance, **p < 0.01. Bars and error bars represent mean and SD, respectively (n = 3). All data were obtained from frozen samples.
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added to the rhesus PC-staining panel, and BM samples from 
three human donors and three rhesus macaques were examined 
(Figures  5A,B). We clearly distinguished a CD138+CD31+ 
human BM PC population that also expressed high levels of 
CD38, while the same staining applied to rhesus macaque BM 
PCs gave only a dim CD38 signal (Figure  5C). Furthermore, 
CD38 expression robustly separated the human CD138+CD31+ 
and CD138+CD31− populations, while this was not the case for 
the corresponding rhesus BM cells (Figure 5D).
The distribution of CD138+CD31+ and CD138+CD31− pop-
ulations was similar in rhesus and human BM samples. However, 
while CD138+CD31+ cells were positive for CD38 in both 
humans (95.6 ± 2.3% of cells defined as CD38++) and macaques 
(91.5 ±  2.8% of cells defined as CD38+) (Figure  5E, left), the 
CD138+CD31− population (Figure 5E, right) was negative for 
CD38 in humans (2.3 ± 0.5%), while a significant proportion of the 
rhesus macaque CD138+CD31− cells (63.9 ± 8.9%, **p < 0.01) 
expressed CD38 to a similar intensity as the CD138+CD31+ 
population. Additionally, we evaluated CD19 expression in 
human CD138+CD31+CD38++ population and in rhesus 
CD138+CD31+CD38+ population, and we found that both 
CD19+ and CD19− populations were clearly distinguishable on 
human cells but less so on rhesus cells (Figures 5A,B). Thus, the 
CD3−CD20low/−CD138+CD31+ staining panel identifies PCs 
in both human and rhesus BM, while markers frequently used to 
define human PCs, CD38 and CD19, are suboptimal for staining 
rhesus macaque BM PCs.
plasmablasts were defined as LiveCD3−CD16−CD14−CD20−/
intHLA-DR+CD80+IC IgG+ cells. Analysis of PBMCs 
collected 0, 7, or 14  days after vaccine inoculation (21) 
corroborated the occurrence of the peak peripheral PC 
response 7  days after immunization (*p  <  0.05, ANOVA 
for repetitive measures) (Figure  4B). We next examined 
if CD14−CD16−CD20low/−HLA-DR+CD80  +  IC IgG+ 
cells from the 7-day time point were CD138+CD31+, 
CD138+CD49d+ or CD138+CD98 and found negligible co-
expression (Figure 4C) but rather single expression of CD31, 
CD49d, and CD98 due to the absence of CD138 expression 
on peripheral PCs (Figure S2B in Supplementary Material), in 
stark contrast to the phenotype of BM-resident PCs that display 
high expression of both CD138 and CD31.
human and Macaque BM Pcs similarly 
co-express cD138 and cD31
Having established that rhesus BM PCs are contained within the 
CD138+CD31+ population, we performed a direct comparison 
between macaque and human BM to determine if the same 
staining panel was suitable for identification of human BM 
PCs. The purpose of this was to perform a qualitative rather 
than quantitative comparison of PC populations in these hosts 
as the number of available human subjects was low. As mentioned 
earlier, CD38 and CD19 are used to define different subsets of 
human BM PCs. Hence, antibodies against these markers were 
FigUre 6 | selective loss of cD138+cD31+ cells in frozen rhesus bone marrow samples. (a) Representative flow cytometry dot plots of CD138+CD31+, 
CD138+CD31−, and CD138− populations gated from live, CD3−CD20low/− cells isolated from fresh and frozen bone marrow. (B) Frequencies of CD138+CD31+ 
(orange) and CD138+CD31− (purple) cells gated from live, single CD3−CD20low/−cells. Kruskal–Wallis test followed by Dunn’s multiple comparison test for 
non-parametric data was performed (n = 12). Significant differences were determined as *p < 0.05, **p < 0.01, and ****p < 0.0001. (c) Pie charts showing 
percentages of CD138+CD31+ (orange) and CD138+CD31− (purple) populations in frozen and fresh samples.
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cryopreservation of Macaque Bone 
Marrow cells results in a selective loss 
of cD138+cD31+ cells
Rhesus macaques are widely used to evaluate immune 
responses induced by vaccine candidates under development 
for human clinical use. In most of these immunization studies, 
samples are collected and immediately frozen for subsequent 
analysis. We observed a striking difference in the frequency of 
CD138+CD31+ cells between fresh and frozen rhesus macaque 
BM cells (Figure 6). When staining fresh and frozen BM from 
a representative animal using the same gating, the frequency of 
CD138+CD31+ population in the LiveCD3−CD20low/− gate 
was 10 times higher in the fresh sample (4.73%) than in the frozen 
sample (0.42%) (Figure 6A). When extending our analysis to BM 
samples from 12 rhesus macaques, we observed a significantly 
higher frequency of CD138+CD31+ cells in fresh samples (4.2 ± 
5.3%) than in the frozen samples (0.8 ± 0.4%) (Figures 6B,C) 
(*p < 0.05, Dunn’s multiple comparison test). The frequency of 
CD138+CD31− cells was similar in fresh and frozen samples 
indicating a selective loss of CD138+CD31+ PCs following 
freezing (Figures  6B,C). The selective loss of CD138+CD31+ 
after the cryopreservation highlights the advantage of working 
with fresh BM samples, which is relevant for studies that aim to 
analyze Ab-secreting PCs in this compartment.
DiscUssiOn
The induction of persistent Ab responses is the goal of most 
prophylactic vaccines. Although rhesus macaques are frequently 
used for preclinical evaluation of human vaccine candidates, a 
comprehensive analysis of the phenotypic and functional proper-
ties of rhesus macaque BM PCs is lacking. Here, we demonstrate 
that IgG-, IgA-, and IgM-secreting rhesus BM PCs were contained 
within the CD31+ population of the CD20low/−CD138+ cells.
CD31 stains both BM PCs and periphery PCs; however, the 
CD20low/−CD138+CD31+ panel was specific for BM PCs as it 
did not stain peak (7 days after a booster immunization) periph-
eral PCs, which are CD138−. Human BM PCs are either CD19+ 
or CD19−, with recent reports demonstrating that long-lived PCs 
are contained in the CD19− compartment (16, 17). In this regard, 
we note that currently available anti−CD19 Abs, including clone 
J3-119, resolve rhesus CD19+ and CD19− populations subopti-
mally. Therefore, we opted to exclude this marker from our panels, 
except in the experiments where direct comparisons with human 
BM were performed. In those experiments, we demonstrate that 
unlike on human cells, both CD20low/−CD138+CD31+ and 
CD20low/−CD138+CD31− rhesus BM cells stained positive for 
CD38, suggesting that this marker is also not suitable to define 
rhesus BM PC.
In addition to CD31, we evaluated the adhesion molecule 
CD49d and the lymphocyte activation antigen CD98 as markers 
for rhesus BM PCs. These markers were previously shown to be 
expressed on human or mouse PCs; CD138, CD31, and CD49d 
are involved in PCs interactions with the BM microenviron-
ment, and their overexpression is a key feature of healthy human 
BM PCs (15, 29, 31). CD31 is expressed on a large number 
of cell types, and it has been used to isolate human PCs from 
BM (32, 33), tonsils (34), lamina propria (31), and spleen (29), 
belongs to the Ig gene superfamily, and is the ligand of CD38 
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(35). CD49d is a transmembrane protein, which associates with 
integrin beta 1 to form the heterodimer VLA-4 and is a prog-
nostic marker for chronic lymphocytic leukemia (CLL) (36, 37). 
CD98 is important for activation, proliferation, and effector 
functions of T and B cells (38, 39) and was recently described as a 
marker for BM PCs in mice (30). We demonstrate here that CD31 
expression correlates strongly with CD49d and CD98 expression 
on CD20low/−CD138+ rhesus BM cells.
In humans, the distribution of PC-produced Ig isotypes varies 
in different organs. For instance, IgG predominates in the BM 
followed by IgA (16, 40), while in the spleen, the distribution is 
more equal (29), and IgA is most abundant in mucosa-associated 
lymphoid tissues (41). In our studies, rhesus BM PCs produced 
primarily IgG (60%), followed by IgA (33%) (16, 40). The pres-
ence of IgA-secreting cells in the BM of rhesus and humans is 
interesting and represents an important area of investigation to 
complement recent reports of PCs in the gut (40, 42, 43). The 
relationship between Ab specificities encoded by antigen-specific 
memory B cells, BM PCs, and circulating Abs is of significant 
interest for our understanding of vaccine-induced responses. 
Data from the mouse model suggest that the peripheral memory 
B cell compartment retains a larger diversity of Ab specificities 
against a given antigen than does the BM PC compartment (44, 
45). In humans, studies have compared the specificities of anti-
gen-specific BM PCs with serum Abs in individuals vaccinated 
with Tetanus toxoid (46) or infected with HIV-1 (47), but so far 
rhesus macaques were not used to address such questions despite 
their frequent use in vaccine evaluation. We also demonstrate a 
selective loss of CD138+CD31+ cells upon cryopreservation of 
BM cells using the conditions described in Section “Materials 
and Methods.” Similarly, others have reported a reduction in the 
frequency of plasmablasts following cryopreservation of PBMCs, 
as shown by both by flow cytometry and B cell ELISpot analyses 
(48). These observations have important implications for studies 
of the Ab repertoires in these compartments.
In conclusion, we show that functional rhesus macaque BM 
PCs secreting IgG, IgA, and IgM are highly enriched in the 
CD20low/−CD138+CD31+ population. These studies offer 
a foundation for studies aimed at investigating the quality of 
long-lived Ab responses in an important primate model and an 
approach for isolating single PCs from the rhesus macaque BM 
compartment for Ab cloning and transcriptional analyses.
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